DED: A New UnderstandingOne of the most frequent causes of patient visits to optometrists, dry eye disease (DED) is both a common and misunderstood problem.
A complex and multidimensional condition, DED has been redefined in the 2017 Tear Film & Ocular Surface Society International Dry Eye Workshop II (TFOS DEWS II) report to reflect the most current understanding of the rapidly evolving science of DED.
Optometrists lead the way in dispelling the misperception that DED is merely a symptom, and in addressing the importance of proper identification and treatment, for both quality of life and to prevent progression to chronic ocular surface disease. This program brings optometrists up-to-date in the new identification and management of DED.
- Krista Flynn ( OD)
- Langis Michaud ( OD, MSc, FAAO (Dipl), FSLS, FBCLA, FEAOO)
- Richard Maharaj (OD, FAAO)
After successful completion of the program, the participant will be able to:
- Describe the role of tear film stability, nociceptive disturbances, and inflammation in dry eye disease (DED) pathogenesis
- Apply the DEWS II report definitions and classifications in diagnosing DED
- Differentiate between therapeutic options for DED
- Manage DED in accordance with Canadian guidelines